SCHEMBL17448248

SCHEMBL17448248

CCCN(CCNC(=O)c1ccc([N+](=O)[O-])cc1)CCc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.68
▸ SMN1; SMN2 Q16637 5/20 0.68
▸ NPC1 O15118 5/20 0.68
▸ TAAR1 Q96RJ0 1/20 0.68
▸ TMEM97 Q5BJF2 3/20 0.65
▸ SIGMAR1 Q99720 3/20 0.65
▸ ALDH1A1 P00352 3/20 0.55
▸ HPGD P15428 2/20 0.55
▸ OPRM1 P35372 1/20 0.53
▸ OPRK1 P41145 1/20 0.53
▸ MAPT P10636 3/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ USP2 O75604 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ DRD2 P14416 1/20 0.52
▸ DRD4 P21917 1/20 0.52
▸ DRD3 P35462 1/20 0.52
▸ PKM P14618 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7915502 0.89 TMEM97 (0.60) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL9827447 0.86 RAB9A (0.60) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL7919653 0.82 TMEM97 (0.62) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL7916125 0.82 HDAC3 (0.60) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL11024162 0.82 RAB9A (1.00) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL3570124 0.81 LMNA (0.65) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL9149818 0.80 TMEM97 (0.59) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
Hydrochloric Acid SCHEMBL9053101 0.80 LMNA (0.66) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL17372434 0.79 SIGMAR1 (1.00) RAB9ASMN1; SMN2NPC1TAAR1TMEM97
SCHEMBL9826975 0.79 SIGMAR1 (0.70) RAB9ASMN1; SMN2NPC1TAAR1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016008011-A1 FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS Novogen ltd (AU) 2016-01-21 — — WO disclosed
Send feedback